Authors’ Reply to Michael Auerbach’s Comment on: “Frequency and Associated Costs of Anaphylaxis- and Hypersensitivity-Related Adverse Events for Intravenous Iron Products in the USA: An Analysis Using the US Food and Drug Administration Adverse Event Reporting System”

Detalles Bibliográficos
Autores principales: Trumbo, Henry, Kaluza, Karolina, Numan, Syed, Goodnough, Lawrence T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053176/
https://www.ncbi.nlm.nih.gov/pubmed/33835350
http://dx.doi.org/10.1007/s40264-021-01059-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8053176/
https://www.ncbi.nlm.nih.gov/pubmed/33835350
http://dx.doi.org/10.1007/s40264-021-01059-x

Ejemplares similares